ERBB2 and lung adenocarcinoma: This is the first study to demonstrate the presence of HER2 amplification in canine lung adenocarcinomas with FISH and also demonstrates that amplification may be associated with a particular type of mutation, the HER2V659E mutation, which can potentially benefit from targeted therapy.